An interventional study of Safety Behavior Fading for Appearance Concerns and Unhealthy Behavior Fading in Body Dysmorphic Disorders, Social Anxiety Disorder and Eating Disorders, sponsored by Florida State University. Completed at 1 site in United States. Open to female participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-05-07.
Sponsored by Florida State University · Not applicable, Interventional, and Treatment
The current study aims to explore the efficacy of a text message based safety behavior fadinig intervention compared to an unhealthy behavior fading intervention for appearance concerns.
Description: Appearance-related safety behavior fading intervention procedures will follow methodology previously used in the Cougle Lab. The safety behavior fading intervention is designed to target a decrease or elimination of appearance-related safety behaviors.
Individuals randomly assigned to the safety behavior fading condition will receive instructions to decrease or eliminate their endorsed appearance-related safety behaviors. In addition, they will receive daily reminders via text message to decrease these behaviors, along with a safety behavior monitoring checklist in which the participant indicates the extent to which they decreased and/or eliminated each safety behavior over the previous day.
Individuals randomly assigned to the unhealthy behavior fading condition will receive instructions to decrease or eliminate unhealthy behaviors. They will also receive daily reminders via text message to decrease these behaviors, along with a safety behavior monitoring checklist in which the participant indicates the extent to which they decreased and/or eliminated each safety behavior over the previous day.
56 studies on the registry are indexed under Body Dysmorphic Disorders; 11 are open to participants now.
This study's enrollment of 203 is above the median of 52 across 44 interventional studies indexed under Body Dysmorphic Disorders.
Browse Body Dysmorphic Disorders studies →Florida State University is the lead sponsor of 249 studies on the registry; 47 are open to participants now.
Of its 16 completed or terminated interventional studies of FDA-regulated products, 9 (56%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Individuals randomly assigned to the safety behavior fading condition will receive instructions to decrease or eliminate their endorsed appearance-related safety behaviors. In addition, they will receive daily reminders via text message to decrease these behaviors, along with a safety behavior monitoring checklist in which the participant indicates the extent to which they decreased and/or eliminated each safety behavior over the previous day.
Behavioral: Safety Behavior Fading for Appearance Concerns
Individuals randomly assigned to the unhealthy behavior fading condition will receive instructions to decrease or eliminate unhealthy behaviors that are unrelated to appearance. They will also receive daily reminders via text message to decrease these behaviors, along with a behavior monitoring checklist in which the participant indicates the extent to which they decreased and/or eliminated each behavior over the previous day.
Behavioral: Unhealthy Behavior Fading
Participants are asked to reduce or eliminate safety behaviors via text message reminders and checklists to monitor progress.
Participants are asked to reduce or eliminate unhealthy behaviors via text message reminders and checklists to monitor progress.
Change in Social Appearance Anxiety Scale
Self-report scale that measures appearance anxiety symptoms. Scores range from 16 to 80 with higher scores indicating higher levels of appearance concerns.
Time frame: Day 0, Day 28, Day 56
Change in Eating Disorder-15
Self-report scale that measures eating disorder symptoms. Scores range from 0 to 90 with higher scores indicating higher levels of eating pathology.
Time frame: Day 0, Day 28, Day 56
Change in Social Phobia Inventory
Self-report scale that measures social anxiety symptoms. Scores range from 0 to 68 with higher scores indicating higher levels of social anxiety.
Time frame: Day 0, Day 28, Day 56
Credibility and Expectancy Questionnaire
Self-report scale for measuring treatment expectancy and rationale credibility for use in clinical outcome studies.
Time frame: Day 0
Change in Appearance Behaviors Checklist
Self-report scale used to measure frequency of engaging in appearance related safety behaviors. This scale will be used as a manipulation check.
Time frame: Day 0, Day 28, Day 56
Change in Unhealthy Behaviors Checklist
Self-report scale used to measure frequency of engaging in unhealthy behaviors. This scale will be used as a manipulation check.
Time frame: Day 0, Day 28, Day 56
Beliefs About Appearance Scale
Self-report scale for measuring appearance importance for use in clinical outcome studies. Each item is rated on a 0-4 scale with a total score range of 0-80 with higher scores indicating greater appearance importance.
Time frame: Day 0, Day 28, Day 56
UCLA Loneliness Scale-8
Self-report scale for measuring loneliness for use in clinical outcome studies. Total scores range from 0 to 32 with higher scores indicating higher loneliness.
Time frame: Day 0, Day 28, Day 56
Center for Epidemiologic Studies Depression Scale
Self-report measure of depression symptom severity.
Time frame: Day 0, Day 28, Day 56
Assessment of ideal self
Self-report measure of appearance importance where individuals must allocate a budget of 100 to 7 different ideals including appearance, creativity, friendliness, work ethic, intelligence, humor, and income.
Time frame: Day 0, Day 28, Day 56
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.